Board Meeting29 Oct 2026, 05:21 pm
Bliss GVS Pharma Board Approves Q2 FY27 Financial Results
AI Summary
Bliss GVS Pharma Ltd announced the outcome of its Board Meeting held on October 29, 2026. The Board reviewed and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. A Limited Review Report from the auditors was also presented. The meeting was conducted via Video Conferencing and concluded within a 1.5-hour timeframe.
Key Highlights
- Board Meeting held on October 29, 2026.
- Approved Unaudited Standalone Financial Results for Q2 FY27.
- Approved Unaudited Consolidated Financial Results for Q2 FY27.
- Limited Review Report from Auditors was enclosed.
- Meeting conducted via Video Conferencing.
Price Impact
More from BLISSGVS